The proportion of CD45+CD11b+F4/80+CD206+CD86- cells (M2 macrophages or TAMs) was significantly lower in the PTX+SHP group compared to the PTX group, indicating a reduced infiltration of tumor-promoting macrophages (Figure 3A). The gene discussed is PTPRC; the disease is neoplasm.